Institutional investors purchased a net $383.0 thousand shares of GHDX during the quarter ended June 2016 and now own 90.60% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAGLE ASSET MANAGEMENT, INC. Bought 291.1 Thousand shares of Genomic Health Inc
BAKER BROS. ADVISORS LP Bought 259.0 Thousand shares of Genomic Health Inc
ALGERT GLOBAL LLC Bought 25.9 Thousand shares of Genomic Health Inc